Benzimidazole and Imidazole Derivatives
Benzimidazole is a compound consisting of a benzene ring fused to an imidazole ring, a five-membered structure containing two nitrogen atoms. Benzimidazole derivatives, such as albendazole, are known for their antiparasitic and antifungal activity, used in the treatment of parasitic infections and certain parasitic diseases in animals and humans. Imidazole, on the other hand, is a five-membered structure with two nitrogen atoms found in various biologically active compounds. Imidazole derivatives, such as metronidazole, have antimicrobial and antiparasitic properties. These compounds are also used in the pharmaceutical industry for treating bacterial infections, parasitic diseases, and some fungal infections, as well as in organic chemistry as catalysts.
At CymitQuimica, we offer high-purity benzimidazoles and imidazoles for research in medicinal chemistry, pharmacology, and biotechnology.
Found 10353 products of "Benzimidazole and Imidazole Derivatives"
Sort by
Purity (%)
0
100
|
0
|
50
|
90
|
95
|
100
(1-Methyl-1H-benzo[d]imidazol-2-yl)(pyridin-4-yl)methanone
CAS:Purity:95.0%Molecular weight:237.261993408203124-bromo-2-{[(1-propyl-1H-benzimidazol-2-yl)amino]methyl}phenol
CAS:Purity:95.0%Molecular weight:360.25500488281251-(6-Methoxy-1H-benzo[d]imidazol-2-yl)-3,5-dimethyl-4-oxo-1,4-dihydropyridine-2-carboxylic acid
CAS:Purity:95.0%Color and Shape:Solid, No data available.Molecular weight:313.31298828125ETHYL 1-CYCLOHEXYL-2-(FURAN-3-YL)-1H-BENZO[D]IMIDAZOLE-5-CARBOXYLATE
CAS:Purity:95.0%Molecular weight:338.4070129394531(E)-2-(4-(1H-Imidazol-4-yl)styryl)-1H-indene-1,3(2H)-dione
CAS:Purity:95.0%Molecular weight:314.343994140625(-)-Donepezil
CAS:Controlled Product<p>Applications (-)-Donepezil is an isomer of Donepezil (D531750), a nootropic, acting as an inhibitor of acetylcholinesterase.<br>References Ohnishi, A., et al.: J. Clin. Pharmacol., 33, 1086 (1993), Galli, A., et al.: Eur. J. Pharmacol., 270, 189 (1994)<br></p>Formula:C24H29NO3Color and Shape:NeatMolecular weight:379.49Itraconazole N,N-Dioxide
Controlled Product<p>Stability Hygroscopic<br>Applications Itraconazole N,N-Dioxide is a derivative of Itraconazole (I937500). Itraconazole is an orally active antimycotic structurally related to Ketoconazole. Antifungal. It is a COVID19-related research product.<br>References Espinel-Ingroff, A., et al.: Antimicrob. Agents Chemother., 26, 5 (1984), Heykants, J., et al.: Mycoses, 32, Suppl 1, 67 (1989), Sugar, A.M.,et al.: Curr. Clin. Top. Infect. Dis., 13, 74 (1993),<br></p>Formula:C35H38Cl2N8O6Color and Shape:NeatMolecular weight:737.632-Amino-5(6)-benzoylbenzimidazole
CAS:<p>Impurity Mebendazole EP Impurity A<br>Applications The minor urinary metabolite of Mebendazole (M200500) in man. Mebendazole impurity.<br>References Leban, J., et al.: Bioorg. Med. Chem. Lett., 17, 5858 (2007),<br></p>Formula:C14H11N3OColor and Shape:NeatMolecular weight:237.266-Bromo-5-(2-fluoro-4-nitrophenoxy)-1-methyl-1H-indazole
CAS:Purity:95.0%Molecular weight:366.14599609375Midazolam 2-Oxide
CAS:Controlled Product<p>Applications A metabolite of Midazolam (M343000).<br></p>Formula:C18H13ClFN3OColor and Shape:NeatMolecular weight:341.77Metronidazole-d4
CAS:Controlled Product<p>Applications Metronidazole-d4 is a labelled analog of Metronidazole (M338880). Used as an antibacterial in the treatment of rosacea. Antiprotozoal (trichomonas). A potential human carcinogen.<br>References Carballo, M., et al.: J. App. Toxicol., 29, 248 (2009), Leitsch, D., et al.: Mol. Microbiol., 72, 518 (2009), Sanderson, H., et al.: Toxicol. Lett., 187, 84 (2009),<br></p>Formula:C62H4H5N3O3Color and Shape:Light YellowMolecular weight:175.18Isobutylsuccinic Acid
CAS:Controlled Product<p>Applications Isobutylsuccinic Acid was used to synthesize succinimide derivatives as inhibitors of human leukocyte elastase, cathepsin G and proteinase 3.<br>References Groutas, W., et al.: Bioorg. Med. Chem., 3, 375 (1995);<br></p>Formula:C8H14O4Color and Shape:NeatMolecular weight:174.19(2-Imidazol-1-yl-ethyl)-methyl-amine
CAS:Formula:C6H11N3Purity:95.0%Color and Shape:SolidMolecular weight:125.175Ilaprazole
CAS:Controlled Product<p>Applications Ilaprazole is a proton pump inhibitor (PPI) used in the treatment of dyspepsia, peptic ulcer disease (PUD), gastroesophageal reflux disease (GORD/GERD) and duodenal ulcer.<br>References Cao, S., et al.: Acta Pharmacol. Sin., 33, 1095 (2012); Wang, L., et al.: J. Clin. Gastroenterol., 45, 322 (2011)<br></p>Formula:C19H18N4O2SColor and Shape:NeatMolecular weight:366.445-Methoxy-2-[(4-methoxy-3,5-dimethylpyridin-2-yl)methanesulfinyl]-1H-1,3-benzodiazole
CAS:Purity:97.0%Color and Shape:SolidMolecular weight:345.4200134277344O-Hydroxyethyl Metronidazole
CAS:Controlled Product<p>Applications O-Hydroxyethyl Metronidazole is the hydroxy ethyl analogue and impurity of the antiprotozoal agent Metronidazole (M338880). O-Hydroxyethyl Metronidazole as well as other 1-substituted-2-methyl-5-nitroimidazoles showed potential antitrichomonal activity.<br>References Kajfez, F. et al.: J. Med. Chem., 11, 167 (1968);<br></p>Formula:C8H13N3O4Color and Shape:Yellowish SolidMolecular weight:215.21rac 5,6-Dehydro Pregabalin
CAS:Controlled Product<p>Applications 5,6-Dehydropregabalin is an impurity of the anticonvulsant, Pregabalin (P704800).<br>References Dousa, M, et al.: J. Pharmac. Biomed. Anal., 53, 717 (2010);<br></p>Formula:C8H15NO2Color and Shape:Off-WhiteMolecular weight:157.2110,11-Dihydro-10-hydroxy Carbamazepine-d3
CAS:Controlled Product<p>Applications A labelled metabolite of Oxcarbazepine (O869250).<br>References Burkhart, C., et al.: Clin. Exp. Allergy, 32, 1635 (2002), Pearce, R., et al.: Drug Metab. Dispos., 30, 1170 (2002), Naisbitt, D., et al.: Mol. Pharmacol., 63, 732 (2003), Farrell, J., et al.: Br. J. Clin. Pharmacol., 57, 690 (2004),<br></p>Formula:C152H3H11N2O2Color and Shape:Off WhiteMolecular weight:257.301-Isopropyl-6-(6-(4-isopropylpiperazin-1-yl)pyridin-3-yl)-N-((6-methyl-2-oxo-4-propyl-1,2-dihydropyridin-3-yl)methyl)-1H-indazole-4-carboxamide
CAS:Purity:98%Color and Shape:SolidMolecular weight:569.7540283203131’-Hydroxy Midazolam-d5
CAS:Controlled Product<p>Applications A labelled metabolite of Midazolam (M343000(P)), which is an anesthetic; anticonvulsant; sedative; hypnotic. Positive allosteric modulator of the GABAA receptor. Neuroprotective & Neuroresearch products.<br>References Dundee, J., et al.: Drugs, 28, 519 (1984), Galetin, A., et al.: Drug Metab. Dispos., 30, 1512(2002), Uchaipichat, V., et al.: Drug Metab. Dispos., 34, 449(2006), Lewis, B., et al.: Biochem. Pharmacol., 73, 1463(2007), Dundee, J. W., et al.: Drugs, 28, 519 (1984), Lahat, E., et al.: Br. Med. J., 321, 83 (2000)<br></p>Formula:C182H5H8ClFN3OColor and Shape:White To Off-WhiteMolecular weight:346.80Voriconazole N-Oxide
CAS:Controlled Product<p>Applications A metabolite of Voriconazole (V760000).<br> Not a dangerous good if item is equal to or less than 1g/ml and there is less than 100g/ml in the package<br>References Sanati, H., et al.: Antimicrob. Ag. Chemother., 41, 2492 (1997), Geist, M., et al.: Antimicrob. Agents. Chemother., 50, 3227 (2006), Yamazaki, H., et al.: Drug. Metab. Dispos., 34, 1803 (2006), Yamazaki, H., et al.: Xenobiotica, 36, 1201 (2006),<br></p>Formula:C16H14F3N5O2Color and Shape:WhiteMolecular weight:365.31Carbamazepine 10,11-Epoxide-d8 (Major)
CAS:Controlled Product<p>Applications A labelled metabolite of Carbamazepine (C175840).<br>References Bellucci, G., et al.: J. Med. Chem., 30, 768 (1987), Johannessen, S., et al.: Ther. Drug. Monit., 27, 710 (2005), Bialer, M., et al.: Expert Opin. Invest. Drugs, 15, 637 (2006), Williams, J., et al.: J. Clin. Pharmacol., 46, 258 (2006),<br></p>Formula:C15H4D8N2O2Color and Shape:White To Dark YellowMolecular weight:260.32Itraconazole-d3
CAS:Controlled ProductFormula:C352H3H35Cl2N8O4Color and Shape:NeatMolecular weight:708.65Itraconazole
CAS:Controlled Product<p>Applications Itraconazole is an orally active antimycotic structurally related to Ketoconazole. Antifungal. It is a COVID19-related research product.<br>References Espinel-Ingroff, A., et al.: Antimicrob. Agents Chemother., 26, 5 (1984); Heykants, J., et al.: Mycoses, 32, Suppl 1, 67 (1989); Sugar, A.M.,et al.: Curr. Clin. Top. Infect. Dis., 13, 74 (1993);<br></p>Formula:C35H38Cl2N8O4Color and Shape:White To Off-WhiteMolecular weight:705.635-Hydroxy Omeprazole-d3 Sodium Salt
CAS:Controlled ProductFormula:C17H15D3N3NaO4SColor and Shape:White To Light YellowMolecular weight:386.42(R)-5-Hydroxymethyl Tolterodine
CAS:Controlled Product<p>Applications A metabolite of Tolterodine (T535800), a muscarinic receptor antagonist used in the treatment of urinary incontinence.<br>References Palmer, L., et al.: J. Pharm. Biomed. Anal., 16, 155 (1997), Hills, C., et al.: Drugs, 55, 813 (1998), Wefer, J., et al.: World J. Urol., 19, 312 (2001),<br></p>Formula:C22H31NO2Color and Shape:NeatMolecular weight:341.491-(Tetrahydro-2H-pyran-2-yl)-1H-indazol-4-amine
CAS:Purity:95.0%Color and Shape:Liquid, No data available.Molecular weight:217.272003173828121-methyl-1,4-dihydro-5H-tetrazol-5-one
CAS:Purity:95.0%Color and Shape:SolidMolecular weight:100.08100128173828Albendazole-d7
CAS:Controlled Product<p>Applications Labelled Albendazole (A511610). An anthelmintic.<br> Not a dangerous good if item is equal to or less than 1g/ml and there is less than 100g/ml in the package<br>References Zhao, Y., et al.: Org. Biomol. Chem., 6, 4509 (2008), Sanderson, H., et al.: Toxicol. Lett., 187, 84 (2009),<br></p>Formula:C12H8D7N3O2SColor and Shape:NeatMolecular weight:272.37Efinaconazole-N-oxide
CAS:Controlled Product<p>Applications Efinaconazole-N-oxide is a degradation product and potentially a metabolite of the anti-fungal drug Efinaconazole (E435070).<br>References Sugiura, K., et. al.: Antimicrob. Agents CH., 58, 3837 (2014);<br></p>Formula:C18H22F2N4O2Color and Shape:NeatMolecular weight:364.39Rufinamide-15N,d2
CAS:Controlled Product<p>Applications Labelled Rufinamide (R701552). Antiepileptic triazole derivative which decreases firing by neurons at sodium channels. Anticonvulsant.<br>References Cheung, W.K., et al.: Pharm. Res., 12, 1878 (1995), Cardot, J.-M., et al.: Biopharm. Drug Dispos., 19, 259 (1998), Palhagen, S., et al.: Epilepsy Res., 43, 115 (2001),<br></p>Formula:C10H6D2F2N315NOColor and Shape:White SolidMolecular weight:241.2rac Desethyl Oxybutynin-d5 Hydrochloride
CAS:Controlled Product<p>Applications A labelled metabolite of the drug Oxybutynin (D289475). Used in the treatment of incontinence.<br>References Hughes, K., et al.: Xenobiotica, 22, 859 (1992), Oki, T., et al.: Biol. Pharm. Bull., 24, 491 (2001), Fetscher, C., et al.: Br. J. Pharmacol., 136, 64 (2002), Zobrist, R., et al.: Pharm. Res., 20, 103 (2003)<br></p>Formula:C20H22D5NO3·HClColor and Shape:White To Off-WhiteMolecular weight:334.47 + (36.46)Propantheline Bromide
CAS:Controlled Product<p>Applications Propantheline is an antimuscarinic agent used in the treatment of hyperhidrosis (excessive sweating), enuresis (involuntary urination) as well as cramps or spasms of the stomach, intestine and bladder.<br>References Levin, R. et al.: Neurol. Urodyn., 1, 221 (1982); Daniotti, S. et al.: Br. J. Pharmacol., 82, 305 (1984); Moller, J. et al .: Acta Med. Scand., 184, 201 (1968);<br></p>Formula:C23H30NO3·BrColor and Shape:White To Off-WhiteMolecular weight:448.39Oxazepam
CAS:Controlled Product<p>Applications Anxiolytic; muscle relaxant (skeletal); anticonvulsant; ligand for the GABAA receptor benzodiazepine modulatory site. Controlled substance (depressant).<br>References Goldenthal, E.I., et al.: Toxicol. Appl. Pharmacol., 18, 185 (1971), Sisenwine, et al.: Arzneim. Forsch., 22, 682 (1972), Shearer, C.M., et al.: Anal. Profiles Drug Subs., 3, 441 (1974), Greenblatt, D.J., et al.: Clin. Pharmacokinet., 6, 89 (1981),<br></p>Formula:C15H11ClN2O2Color and Shape:White To Off-WhiteMolecular weight:286.71Modafinil Carboxylate Methyl Ester
CAS:Controlled Product<p>Impurity Modafinil EP Impurity C<br>Applications Modafinil Carboxylate Methyl Ester (Modafinil EP Impurity C) is a Modafinil derivative.<br>References Lehr, H., et al.: J. Med. Chem., 6, 136 (1963), Saikawa, I., et al.: Chem. Pharm. Bull., 33, 5534 (1985),<br></p>Formula:C16H16O3SColor and Shape:NeatMolecular weight:288.363,5-Dimethyl-2-pyridinemethanol
CAS:Controlled Product<p>Applications Intermediate in the preparation of Omeprazole metabolites<br></p>Formula:C8H11NOColor and Shape:Colourless To BrownMolecular weight:137.179Oxybutynin N-Oxide 90%
CAS:Controlled Product<p>Applications A metabolite of Oxybutynin.<br>References Hughes, K., et al.: Xenobiotica, 22, 859 (1992), Oki, T., et al.: Biol. Pharm. Bull., 24, 491 (2001), Fetscher, C., et al.: Br. J. Pharmacol., 136, 64 (2002), Zobrist, R., et al.: Pharm. Res., 20, 103 (2003)<br></p>Formula:C22H31NO4Purity:90%Color and Shape:NeatMolecular weight:373.49N-Demethyl Trimebutine-d5 Hydrochloride
CAS:Controlled Product<p>Applications The main bioactive labelled metabolite of Trimebutine.<br>References Miura, Y., et al.: Drug Metab. Dispos., 17, 455 (1989), Xue, L., et al.: Eur. J. Pharmacol., 294, 75 (1995), Roman, F., et al.: J. Pharmacol. Exp. Ther., 289, 1391 (1999), Kayser, V., et al.: Life Sci., 66, 433 (2000),<br></p>Formula:C21H22D5NO5·HClColor and Shape:NeatMolecular weight:414.93Scopolamine-d3 Hydrobromide Hydrate
CAS:Controlled Product<p>Stability Hygroscopic<br>Applications An acetylcholine antagonist. Used in treatment of motion sickness; antiemetic; antispasmodic; mydriatic; preanesthetic medicant.<br> Not a dangerous good if item is equal to or less than 1g/ml and there is less than 100g/ml in the package<br>References Brand, J.J., et al.: Lancet, 2, 232 (1970), Bowles, J.B., et al.: Anaesthesia, 34, 476 (1979), Clissold, S.P., et al.: Drugs, 29, 189 (1985), Muhtadi, F.J., et al.: Anal. Profiles Drug Subs., 19, 477 (1990),<br></p>Formula:C17H18D3NO4·BrH·xH2OColor and Shape:NeatMolecular weight:387.284-(1H-1,2,4-Triazol-1-ylmethyl)benzonitrile
CAS:Controlled ProductFormula:C10H8N4Color and Shape:WhiteMolecular weight:184.208(9)-Methoxy-1,3-dimethyl-12-thioxopyrido[1’,2’:3,4]imidazo[1,2-a]benzimidazol-2-(12H)-one (Mixture of Regioisomers)
CAS:Controlled Product<p>Impurity Omeprazole EP Impurity F+Omeprazole EP Impurity G<br>Stability Sample unstable under MS condition<br>Applications 8(9)-Methoxy-1,3-dimethyl-12-thioxopyrido[1’,2’:3,4]imidazo[1,2-a]benzimidazol-2-(12H)-one(Mixture of Regioisomers) (Omeprazole EP Impurity F+Omeprazole EP Impurity G) is a mixture of regioisomers of Omeprazole Impurity.<br>References Rackur, G., et al.: Biochem. Biophys. Res. Commmun., 128, 477 (1985),<br></p>Formula:C16H13N3O2SColor and Shape:NeatMolecular weight:311.364'-Ethoxyacetophenone
CAS:<p>Applications 4'-Ethoxyacetophenone, is an acetophenone derivative that can be used as an antibacterial agent. It is a reagent for plymerization. It can also be used as a flavoring agent in fabricating cigarettes with flavored filter tips.<br>References Sivakumar, P., et al.: Chem. Bio. Drug Design, 72, 303 (2008); Mathis, D. E., Beitraege zur Tabakforschung Int., 12, 1 (1983);<br></p>Formula:C10H12O2Color and Shape:White To Off-WhiteMolecular weight:164.202-Fluoro-1H-imidazole hydrochloride
CAS:Purity:95.0%Color and Shape:SolidMolecular weight:122.529998779296885-Desamino 5-Oxo-2,5-dihydro Lamotrigine
CAS:Controlled Product<p>Impurity Lamotrigine EP Impurity A; Lamotrigine USP Related Compound C<br>Applications 5-Desamino 5-Oxo-2,5-dihydro Lamotrigine (Lamotrigine EP Impurity A; Lamotrigine USP Related Compound C) is an impurity of the anticonvulsant Lamotrigine (L173250).<br> Not a dangerous good if item is equal to or less than 1g/ml and there is less than 100g/ml in the package<br>References Srinivasulu, P. et al.: Chromatographia, 70, 271 (2009);<br></p>Formula:C9H6Cl2N4OColor and Shape:White SolidMolecular weight:257.08Rufinamide
CAS:<p>Applications Antiepileptic triazole derivative which decreases firing by neurons at sodium channels. Anticonvulsant. Neuroprotective & Neuroresearch Product.<br>References Cheung, W.K., et al.: Pharm. Res., 12, 1878 (1995), Cardot, J.-M., et al.: Biopharm. Drug Dispos., 19, 259 (1998), Palhagen, S., et al.: Epilepsy Res., 43, 115 (2001),<br></p>Formula:C10H8F2N4OColor and Shape:White To Off-WhiteMolecular weight:238.19Atropine Sulfate Monohydrate
CAS:Controlled Product<p>Applications Mydriatic; antispasmodic; used in preanesthetic medication.<br> Not a dangerous good if item is equal to or less than 1g/ml and there is less than 100g/ml in the package<br>References Brown, R.V., et al.: Br. J. Pharmacol., 15, 170 (1960), Shutt, L.E., et al.: Anaesthesia, 34, 476 (1979), Hinderling, P.H., et al.: J. Pharm. Sci., 74, 703 (1985),<br></p>Formula:C17H23NO3·H2O·H2O4SColor and Shape:White To Light YellowMolecular weight:694.83Iso Letrozole
CAS:<p>Impurity Letrozole EP Impurity A; Letrozole USP Related Compound A<br>Applications Isoletrozole (Letrozole EP Impurity A) is an impurity of Letrozole (L330100). Letrozole impurity A as per USP.<br>References Fleming, F.F., et al.: J. Med. Chem., 53, 7902 (2010),<br></p>Formula:C17H11N5Color and Shape:NeatMolecular weight:285.30Glycopyrrolate Bromide-d3 (Mixture of Diastereomers)
CAS:Controlled Product<p>Applications Labelled analogue of Glycopyrrolate Bromide, a novel pharmaceutical compound based on PDE IV inhibitors. Glycopyrrolate Bromide is used in the treatment of respiratory complaints.<br>References Gomez, et al.: Br. J. Anaesth., 74, 549 (1995);<br></p>Formula:C19H25D3NO3·BrColor and Shape:NeatMolecular weight:401.35Oxcarbazepine
CAS:<p>Applications A metabolite of Eslicarbazepine acetate, (BIA 2-093), a novel central nervous system drug. A keto derivative of Carbamazepine. Used as an anticonvulsant. Neuroprotective & Neuroresearch Product.<br>References Dam., M., et al.: Epilepsy Res., 3, 70 (1989); Beydoun, A., et al.: Expert Opin. Pharmacother., 3, 59 (2001);<br></p>Formula:C15H12N2O2Color and Shape:Light YellowMolecular weight:252.27(R)-(-)-3-(Carbamoylmethyl)-5-methylhexanoic acid
CAS:Controlled Product<p>Applications An impurity of the anti-convulsant (S)-Pregabalin (P704790).<br>References Lin, S. et al.: J. Liq. Chrom. Rel. Technol., 19, 2699 (1996); Sripathi, S. et al.: ARKIVOC, 10, 266 (2010);<br></p>Formula:C9H17NO3Color and Shape:White To Off-WhiteMolecular weight:187.24Oxybutynin Chloride
CAS:Controlled Product<p>Applications An inhibitor of proliferation and supresses gene expression in bladder smooth muscle cells.<br>References Park, J.M., et al.: J. Urol., 162, 1110 (1999), Watson, M., et al.: Brit. J. Pharmacol., 127, 590 (1999)<br></p>Formula:C22H31NO3·ClHColor and Shape:White To Off-WhiteMolecular weight:393.953-Hydroxy Carbamazepine
CAS:<p>Applications A metabolite of Carbamazepine (C175840).<br>References Park, B., et al.: Biochem. Pharmacol., 36, 581 (1987), Yamazaki, H., et al.: Drug Metab. Dispos., 27, 1260 (1999), Dieckhaus, C., et al.: Chem. Res. Toxicol., 14, 958 (2001),<br></p>Formula:C15H12N2O2Color and Shape:NeatMolecular weight:252.275-(S-Methyl) Albendazole
CAS:<p>Impurity Albendazole EP Impurity F<br>Applications 5-(S-Methyl) Albendazole is a metabolite of Albendazole (A511610). Albendazole EP Impurity F<br>References Gyurik, R.J., et al.: Drug Metab. Dispos., 9, 503 (1981),<br></p>Formula:C10H11N3O2SColor and Shape:NeatMolecular weight:237.28N-(2-Hydroxyethyl)-5-methyl-1,2,4-oxadiazole-3-carboxamide
CAS:<p>Applications N-(2-Hydroxyethyl)-5-methyl-1,2,4-oxadiazole-3-carboxamide is a photolysis product of Metronidazole (M338880), an antibiotic.<br>References Moore, Douglas E., et al.: Radiation Phy. and Chem., 36(4), 547-50 (1990)<br></p>Formula:C6H9N3O3Color and Shape:NeatMolecular weight:171.154Thiabendazole-d4 (Major)
CAS:Controlled ProductFormula:C10D4H3N3SColor and Shape:Off WhiteMolecular weight:205.271-(5-Bromopyrimidin-2-yl)-1H-benzo[d]imidazol-2(3H)-one
CAS:Purity:95.0%Molecular weight:291.10800170898441-[(2-FLUOROPHENYL)-(4-FLUOROPHENYL)-PHENYLMETHYL]IMIDAZOLE
CAS:Purity:98.0%Molecular weight:346.3810119628906Tert-Butyl 6-(benzyloxy)-4-fluoro-1H-indazole-1-carboxylate
CAS:Purity:95.0%Molecular weight:342.36999511718752-Methyl-5-nitroimidazole
CAS:<p>Impurity Tinidazole EP Impurity A/ Metronidazole EP Impurity A<br>Applications 2-Methyl-5-nitroimidazole (Tinidazole EP Impurity A) is a Floconazole impurity.<br>References Sanderson, H., et al.: Toxicol. Lett., 187, 84 (2009), Kumar, L., et al.: Eur. J. Med. Chem., 45, 817 (2010),<br></p>Formula:C4H5N3O2Color and Shape:Light YellowMolecular weight:127.10NAP 226-90
CAS:<p>Impurity Rivastigmine EP Impurity A; Rivastigmin USP Related Compound C<br>Applications NAP 226-90 (Rivastigmine EP Impurity A; Rivastigmin USP Related Compound C) is a S-Enantiomer metabolite of Rivastigmine, a brain selective acetylcholinesterase inhibitor.<br>References Rosler, M., et al.: Br. Med. J., 318, 633 (1999), Jann, M., et al.: Clin. Pharmacokinet., 41, 719 (2002), Frankfort, S., et al.: Int. J. Clin. Pract., 60, 646 (2006),<br></p>Formula:C10H15NOColor and Shape:WhiteMolecular weight:165.23N-Methyl Omeprazole (Mixture of isomers with the methylated nitrogens of imidazole)
CAS:Controlled Product<p>Applications Omeprazole (O635000) impurity.<br>References Allenmark, S., et al.: Anal. Biochem., 136, 293 (1984), Besancon, M., et al.: J. Biol. Chem., 272, 22438 (1997),<br></p>Formula:C18H21N3O3SColor and Shape:Off White SolidMolecular weight:359.442-Nitroamino-2-imidazoline
CAS:Controlled Product<p>Applications 2-Nitroamino-2-imidazoline is a neonicotinoid substituents that forms water bridge at nicotinic acetylcholine receptor.<br>References Ohno, I., et al.: J. Agr. Food. Chem., 57, 2436 (2009); Nishiwaki, H., et al.: J. Pest. Sci., 29, 110 (2004);<br></p>Formula:C3H6N4O2Color and Shape:NeatMolecular weight:130.11Letrozole-d4 (major)
CAS:Controlled ProductFormula:C17D4H7N5Color and Shape:Yellowish SolidMolecular weight:289.332-(2-Cyclopropyl-7-fluoro-1H-1,3-benzodiazol-1-yl)acetic acid
CAS:Molecular weight:234.22999572753906Thiabendazole
CAS:Controlled Product<p>Applications A drug used in the treatment of helminthiases.<br> Not a dangerous good if item is equal to or less than 1g/ml and there is less than 100g/ml in the package<br>References Tocco, D.J., et al.: J. Med. Chem., 7, 399 (1964), Robinson, H.J., et al.: Toxicol. Appl. Pharmacol., 7, 53 (1965), Kates, K.C., et al.: J. Parasitol., 57, 356 (1971), Kapoor, V.K., et al.: Anal. Profiles Drug Subs., 16, 611 (1986),<br></p>Formula:C10H7N3SColor and Shape:NeatMolecular weight:201.25Desnitro-imidacloprid Hydrochloride
CAS:Controlled ProductFormula:C9H11ClN4·ClHColor and Shape:Light Orange GreyMolecular weight:247.122,3-Diphenyl-5-(thiophen-2-yl)-2H-tetrazol-3-ium chloride
CAS:Purity:98%Molecular weight:340.8299865722656Carbamazepine-d8(Major)
CAS:Controlled Product<p>Applications Labelled Carbamazepine (C175840). Used in treatment of pain associated with trigeminal neuralgia. Anticonvulsant.<br>References Stenger, E.G., et al.: Med. Exp., 11, 191 (1964), Pynnonen, S., et al.: Ther. Drug Monit., 1, 409 (1979), Sidebottom, A., et al.: J. Clin. Pharm. Ther., 20, 31 (1995)<br></p>Formula:C15H4D8N2OColor and Shape:NeatMolecular weight:244.32Ornidazole Isomer (Impurity)
CAS:Controlled Product<p>Applications An isomeric impurity of Ornidazole (0688500), which maintains anti-infective properties.<br>References Hoffer, M., et al.: J. Med. Chem., 17, 1019 (1974);<br></p>Formula:C7H10ClN3O3Color and Shape:NeatMolecular weight:219.634-Ethyl-5-fluoropyrimidine
CAS:<p>Impurity Voriconazole EP Impurity C<br>Stability Volatile<br>Applications 4-Ethyl-5-fluoropyrimidine (Voriconazole EP Impurity C) is a Voriconazole (V760000) impurity.<br>References Miletic, T. et al.: Carb. polym., 98, 122 (2013); Rieke, R., et al.: Science, 246, 1260 (1989), Dickinson, R., et al.: Bioorg. Med. Chem. Lett., 6, 2031 (1996),<br></p>Formula:C6H7FN2Color and Shape:NeatMolecular weight:126.135-(4'-(BROMOMETHYL)-[1,1'-BIPHENYL]-2-YL)-2-TRITYL-2H-TETRAZOLE
CAS:Purity:95%Molecular weight:557.4949951171875α,α,2,6-Tetrachloro-toluene
CAS:Controlled Product<p>Impurity Isoconazole Impurity 9<br>Applications α,α,2,6-Tetrachloro-toluene (Isoconazole Impurity 9) is an impurity of Isoconazole (I798250), an antibacterial and antifungal agent used to treat vaginitis.<br> Not a dangerous good if item is equal to or less than 1g/ml and there is less than 100g/ml in the package<br>References Asikoglu, M. et al.: J. Pharm. Pharmacol. 47, 717 (1995); Marrero-Ponce, Y. et al.: Bioorg. Med. Chem. 13, 2881 (2005)<br></p>Formula:C7H4Cl4Color and Shape:Light YellowMolecular weight:229.92Temazepam Acetate
CAS:Controlled Product<p>Applications Temazepam Acetate is an impurity of temazepam (T017200), which is a pharmacologically active metabolite of Diazepam. It is used as a sedative and hypnotic drug.<br>References Sarteschi, P., et al.: Arzneim.-Forsch., 22, 93 (1972), Schwandt, H.J., et al.: Xenobiotica, 4, 733 (1974), Curry, S.H., et al.: Br. J. Pharmacol., 57, 427 (1976), Heel, R.C., et al.: Drugs, 21, 321 (1981),<br></p>Formula:C18H15ClN2O3Color and Shape:White To Off-WhiteMolecular weight:342.785-Methyl Zolpidem
CAS:Controlled Product<p>Applications An impurity of Zolpidem (Z650000).<br></p>Formula:C19H21N3OColor and Shape:NeatMolecular weight:307.393-Bromo Zolpidem
Controlled ProductFormula:C19H20BrN3OColor and Shape:White To Off-WhiteMolecular weight:386.29Neticonazole
CAS:<p>Neticonazole has anti-infective and anti-cancer effects, inhibits exosome secretion, and can be used to study Candida albicans infection of the skin.</p>Formula:C17H22N2OSPurity:99.58%Color and Shape:SolidMolecular weight:302.43O-Acetyl Scopolamine Hydrobromide
CAS:Controlled Product<p>Applications Scopolamine Hydrobromide (S200000) derivative. An acetylcholine antagonist. Used in treatment of motion sickness; antiemetic; antispasmodic; mydriatic; preanesthetic medicant.<br> Not a dangerous good if item is equal to or less than 1g/ml and there is less than 100g/ml in the package<br>References Brand, J.J., et al.: Lancet, 2, 232 (1970), Bowles, J.B., et al.: Anaesthesia, 34, 476 (1979), Clissold, S.P., et al.: Drugs, 29, 189 (1985), Muhtadi, F.J., et al.: Anal. Profiles Drug Subs., 19, 477 (1990),<br></p>Formula:C19H24BrNO5Color and Shape:NeatMolecular weight:426.3Isavuconazole-d4
CAS:Controlled Product<p>Applications Labelled Isavuconazole (I777832). It is a new triazole currently undergoing phase III clinical trials. This compound has shown in vitro activity against a large number of clinical important yeasts and molds including Aspergillus spp., Fusarium spp., Scedosporium spp., Candida spp., the Zygomycetes and Cryptococcus spp.<br>References Ohwada, J., et al.: Bioorg. Med. Chem. Lett., 13, 191 (2003), Guinea, J., et al.: Antimicrob. Agents Chemother., 52, 1396 (2008)<br></p>Formula:C22H13D4F2N5OSColor and Shape:White To YellowMolecular weight:441.49Lansoprazole Sulfide N-Oxide
CAS:<p>Applications Used in the preparation of Lansoprazole and its metabolite and impurities.<br>References Reddy, G. et al.; Synthetic Commun. 38, 3477 (2008)<br></p>Formula:C16H14F3N3O2SColor and Shape:Off White SolidMolecular weight:369.36Ethyl Chloroacetate
CAS:Controlled ProductFormula:C4H7ClO2Color and Shape:ColourlessMolecular weight:122.55(S)-Pregabalin
CAS:Controlled Product<p>Applications S-Enantiomer of Pregabalin. A GABA analogue used as an anticonvulsant. Anxiolytic analgesic used to treat peripheral neuropathic pain and fibromyalgia.<br>References Taylor, C.P., at al.: Epilepsy Res., 14, 11 (1993); Field, M.J., et al.: Pain, 80, 391 (1999);<br></p>Formula:C8H17NO2Color and Shape:Off-WhiteMolecular weight:159.235-Amino-1-methyl-1H-benzimidazole-2-butanoic acid ethyl ester
CAS:Formula:C14H19N3O2Purity:95.0%Color and Shape:SolidMolecular weight:261.325Ornidazole
CAS:<p>Applications Anti-infective.<br>References Grunberg, E, et al.: Proc. Soc. Exp. Biol. Med., 133, 490 (1970), Hoffer, M., et al.: J. Med. Chem., 17, 1019 (1974), Schwartz, D.E., et al.: Chemotherapy, 22, 19 (1976),<br></p>Formula:C7H10ClN3O3Color and Shape:Off-WhiteMolecular weight:219.632-(3-Chloro-thiophen-2-yl)-1H-benzoimidazole-5-carboxylic acid
CAS:Color and Shape:SolidMolecular weight:278.7099914550781Lamotrigine-13C3,d3, Major
CAS:Controlled Product<p>Applications An isotopically labelled Lamotrigine (L173250), an anticonvulsant. Inhibits glutamate release, possible through inhibition of Sodium, Potassium and Calcium currents. Used in treatment of bipolar depression.<br> Not a dangerous good if item is equal to or less than 1g/ml and there is less than 100g/ml in the package<br>References Miller, A.A., et al.: Epilepsia, 27, 483 (1986), Grunze, et al.: Neuropsychobiology, 38, 131 (1998), Calabrese, J.R., et al.: J. Clin. Psychiatry, 60, 79 (1999),<br></p>Formula:C3C62H3H4Cl2N5Color and Shape:Off-White To Light YellowMolecular weight:262.09
![(1-Methyl-1H-benzo[d]imidazol-2-yl)(pyridin-4-yl)methanone](/_next/image/?url=https%3A%2Fstatic.cymitquimica.com%2Fproducts%2F10%2Fthumb-webp%2FF458070.webp&w=3840&q=75)
![4-bromo-2-{[(1-propyl-1H-benzimidazol-2-yl)amino]methyl}phenol](/_next/image/?url=https%3A%2Fstatic.cymitquimica.com%2Fproducts%2F10%2Fthumb-webp%2FF315007.webp&w=3840&q=75)
![(1H-Benzo[d]imidazol-5-yl)(phenyl)methanone](/_next/image/?url=https%3A%2Fstatic.cymitquimica.com%2Fproducts%2F10%2Fthumb-webp%2FF215094.webp&w=3840&q=75)
![1-(6-Methoxy-1H-benzo[d]imidazol-2-yl)-3,5-dimethyl-4-oxo-1,4-dihydropyridine-2-carboxylic acid](/_next/image/?url=https%3A%2Fstatic.cymitquimica.com%2Fproducts%2F10%2Fthumb-webp%2FF448259.webp&w=3840&q=75)
![1-((4-Nitrophenyl)sulfonyl)-1h-benzo[d]imidazole](/_next/image/?url=https%3A%2Fstatic.cymitquimica.com%2Fproducts%2F10%2Fthumb-webp%2FF745669.webp&w=3840&q=75)
![ETHYL 1-CYCLOHEXYL-2-(FURAN-3-YL)-1H-BENZO[D]IMIDAZOLE-5-CARBOXYLATE](/_next/image/?url=https%3A%2Fstatic.cymitquimica.com%2Fproducts%2F10%2Fthumb-webp%2FF388803.webp&w=3840&q=75)
![5-Methoxy-2-[(4-methoxy-3,5-dimethylpyridin-2-yl)methanesulfinyl]-1H-1,3-benzodiazole](/_next/image/?url=https%3A%2Fstatic.cymitquimica.com%2Fproducts%2F10%2Fthumb-webp%2FF358068.webp&w=3840&q=75)
![8(9)-Methoxy-1,3-dimethyl-12-thioxopyrido[1’,2’:3,4]imidazo[1,2-a]benzimidazol-2-(12H)-one (Mixtur…](/_next/image/?url=https%3A%2Fstatic.cymitquimica.com%2Fproducts%2FTR%2Fthumb-webp%2FM262560.webp&w=3840&q=75)
![1-(5-Bromopyrimidin-2-yl)-1H-benzo[d]imidazol-2(3H)-one](/_next/image/?url=https%3A%2Fstatic.cymitquimica.com%2Fproducts%2F10%2Fthumb-webp%2FF363663.webp&w=3840&q=75)
![1-[(2-FLUOROPHENYL)-(4-FLUOROPHENYL)-PHENYLMETHYL]IMIDAZOLE](/_next/image/?url=https%3A%2Fstatic.cymitquimica.com%2Fproducts%2F10%2Fthumb-webp%2FF538745.webp&w=3840&q=75)
![5-(4'-(BROMOMETHYL)-[1,1'-BIPHENYL]-2-YL)-2-TRITYL-2H-TETRAZOLE](/_next/image/?url=https%3A%2Fstatic.cymitquimica.com%2Fproducts%2F10%2Fthumb-webp%2FF793520.webp&w=3840&q=75)
